Table 1 Background of patients enrolled in this study at hospitalization.
From: Cardiac mitofusin-1 is reduced in non-responding patients with idiopathic dilated cardiomyopathy
Responder | Non-responder | p value | n | ||
|---|---|---|---|---|---|
At hospitalization | Age (years) | 58.1 ± 12.1 | 56.5 ± 13.5 | 0.772 | 14.8 |
Height (cm) | 166.3 ± 9.9 | 164.2 ± 9.1 | 0.622 | 14.8 | |
Weight (kg) | 72.4 ± 16.2 | 66.3 ± 22.0 | 0.462 | 14.8 | |
Heart rate (bpm) | 98.7 ± 31.2 | 85.6 ± 28.4 | 0.34 | 14.8 | |
Systolic pressure (mmHg) | 128.6 ± 33.3 | 122.4 ± 33.2 | 0.675 | 14.8 | |
Diastolic pressure (mmHg) | 75.9 ± 26.9 | 76.1 ± 12.3 | 0.979 | 14.8 | |
Echocardiogram | LVDd (mm) | 58.3 ± 4.4 | 61.2 ± 9.0 | 0.415 | 14.8 |
LVDs (mm) | 49.7 ± 3.4 | 51.1 ± 8.9 | 0.693 | 14.8 | |
EF (%) | 31.1 ± 8.4 | 33.4 ± 9.9 | 0.566 | 14.8 | |
Catheter | LVSP (mmHg) | 126.0 ± 27.1 | 110.0 ± 26.7 | 0.336 | 10.4 |
LVEDP (mmHg) | 10.0 ± 9.9 | 16.8 ± 7.6 | 0.242 | 11.4 | |
mean PAP (mmHg) | 17.5 ± 7.7 | 18.6 ± 8.6 | 0.755 | 14.8 | |
mean RAP (mmHg) | 3.1 ± 2.96 | 3.1 ± 3.6 | 0.974 | 13.8 | |
CI (ml/min/m2) | 2.8 ± 0.8 | 2.2 ± 0.5 | 0.114 | 14.7 | |
Lab | Cre (g/dL) | 2.1 ± 2.8 | 0.9 ± 0.3 | 0.153 | 14.8 |
Hb (g/dL) | 13.7 ± 2.6 | 13.9 ± 1.3 | 0.796 | 14.8 | |
BNP (pg/ml) | 599.8 ± 548.4 | 501.4 ± 521.9 | 0.686 | 13.8 | |
Drugs | β blocker | 3(25.0%) | 6(75.0%) | 0.028 | 12.8 |
ACE-i/ARB | 6(50.0%) | 5(62.5%) | 0.582 | 12.8 | |
Spironolactone | 3(25.0%) | 4(50.0%) | 0.251 | 12.8 | |
Diuretics | 6(50.0%) | 6(75.0%) | 0.264 | 12.8 | |
Amiodarone | 0(0%) | 0(0%) | NS | 12.8 | |
